Stockreport

UPDATE 1-FDA approves Intra-Cellullar's schizophrenia treatment, shares soar [Reuters]

H LUNDBECK A/S S/ADR  (HLUYY) 
NASDAQ:AMEX Investor Relations: investor.lundbeck.com
PDF UPDATE 1-FDA approves Intra-Cellullar's schizophrenia treatment, shares soar (Adds background, shares, company comment) Dec 23 (Reuters) - The U.S. Food and Drug Adminis [Read more]